A study was performed of the reactions of protonated acetic acid hydrates, CH3COOHH+(H2O)n, with acetone molecules, CH3COCH3, using a selected ion flow-drift tube (SIFDT). The rationale for this study is that hydrated protonated organic molecules are major product ions in secondary electrospray ionization mass spectrometry (SESI-MS) and ion mobility spectrometry (IMS). Yet the formation and reactivity of these hydrates are only poorly understood, and kinetics data are only sparse. The existing SIFDT instrument in our laboratory was upgraded to include an octupole ion guide and a separate drift tube by which hydrated protonated ions can be selectively injected into the drift tube reactor and their reactions with molecules studied under controlled conditions. This case study shows that, in these hydrated ion reactions with acetone molecules, the dominant reaction process is ligand switching producing mostly proton-bound dimer ions (CH3COCH3)H+(CH3COOH), with minor branching into (CH3COCH3)H+(H2O). This switching reaction was observed to proceed at the collisional rate, while other studied hydrated ions reacted more slowly. An attempt is made to understand the reaction mechanisms and the structures of the reaction intermediate ions at the molecular level.  https://www.selleckchem.com/products/apilimod.html  Secondary switching reactions of the asymmetric proton-bound dimer ions lead to a formation of strongly bound symmetrical dimers (CH3COCH3)2H+, the terminating ion in this ion chemistry. These results strongly suggest that, in SESI-MS and IMS, the presence of a polar compound, like acetone in exhaled breath, can suppress the analyte ions of low concentration compounds like acetic acid thus compromising their quantification.A growing body of evidence suggests that the post-mortem interval exerts a strong effect on the metabolome, independently of the biological matrix or the cause of death. A sound and shared approach in standardization is mandatory.The sorption of Ni(II) by green rust sulfate (GR-sulfate) was studied in anoxic pre-equilibrated suspensions at pH 7.0 and pH 7.8 with combined batch kinetic experiments, X-ray diffraction measurements, and Ni K-edge X-ray absorption spectroscopy (XAS) analyses. Continuous removal of aqueous Ni(II) was observed over the course of the reaction (1-2.5 weeks) at both pH values, with no concurrent changes in aqueous Fe(II) levels or detectable mineralogical modifications of the GR sorbent. XAS results indicate that Ni(II) is not retained as mononuclear adsorption complexes on the GR surface but rather incorporated in the octahedral layers of an FeII0.67-xNiIIxFeIII0.33(OH)2-layered double hydroxide (LDH) phase with 0 less then x less then 0.67. The combined macroscopic and spectroscopic data suggest that Ni(II) substitutes into the GR lattice during Fe(II)-catalyzed recrystallization of the sorbent and/or forms secondary Ni(II)/Fe(II)-Fe(III)-LDH phases with a higher stability than that of GR, complemented likely by Ni(II)-Fe(II) exchange at GR particle edges. The results of this study reveal GR to be a dynamic sorbent that engages in dissolution-reprecipitation and exchange reactions, causing extensive incorporation of trace metal Ni(II)aq. Additional work is needed to further define the mechanisms involved and to assess the sorptive reactivity of GR with other trace metal species.Speciation analysis of arsenic in blood is essential for identifying and quantifying the exposure of arsenic and studying the metabolism and toxicity of arsenic. Herein, a novel pretreatment device is rationally designed and used for speciation analysis of arsenic in whole blood by ion chromatography-inductively coupled plasma-mass spectrometry (IC-ICP-MS). The sample centrifuge tubes containing blood, reagents, and a magnetic stir bar are placed on the fidget spinner of the pretreatment device. When flicking the fidget spinner rotation with the finger, the magnetic stir bar in the tube rotates in three dimensions under the magnetic field, thereby assisting dispersive extraction of arsenic species by the mixing of blood with reagents. Afterward, the arsenic extract is separated in situ from the blood matrix using an ultrasonic spray sheet covered with a filter and ultrafiltration membrane, which is directly used for subsequent IC-ICP-MS analysis. For 100 μL of blood, the whole pretreatment operation can be completed within 10 min. With As(III), As(V), MMA, and DMA in blood as analytes, the use of the present pretreatment device will hardly lead to the loss and transformation of arsenic species, and the extraction efficiency of the total arsenic is more than 96%. When the pretreatment device is coupled to IC-ICP-MS, the detection limits of four arsenic species in whole blood are 0.017-0.023 μg L-1, and precisions are within 2.3-4.2%. This pretreatment device provides a simple, fast, efficient, and low-cost tool for extraction and separation of arsenic species in whole blood, opening a new idea for the pretreatment of complex samples.Cellulose nanocrystals (CNCs) of 180 nm length and 8 nm diameter were deposited on porous supports by tangential flow filtration followed by salt permeation to form ultrafiltration membranes. At a high enough shear rate on the support surface, CNCs aligned in the direction of flow, showing a nematic order. The shear rates for transition to the nematic phase determined from rheology analysis, polarized optical microscopy, and membrane performance were consistent with one another, at ca. 10 s-1. Permeating an AlCl3 solution through the shear-aligned CNC deposit stabilized the CNC layer by screening repulsive electrostatic interactions, and the stable CNC layer was obtained. On changing the surface shear rate from 10 to 50 s-1, the order parameter of CNCs increased from 0.17 to 0.7 and the rejection for Blue Dextran (5 kDa) increased from 80.4 to 92.7% and that for β-lactoglobulin (18 kDa) increased from 89.6 to 95.4%. Hence, a simple and scalable method for controlling rejection properties of ultrafiltration membranes is developed, which uses aqueous CNC suspensions to form the selective layer.Chemotherapy has seen great progress in the development of performant treatment strategies. Nanovesicles such as liposomes and polymersomes demonstrated great potential in cancer therapy. However, these nanocarriers deliver their content passively, which faces a lot of constraints during blood circulation. The main challenge resides in degradation and random delivery to normal tissues. Hence, targeting drug delivery using specific molecules (such as antibodies) grafted over the surface of these nanocarriers came as the answer to overcome many problems faced before. The advantage of using antibodies is their antigen/antibody recognition, which provides a high level of specificity to reach treatment targets. This review discusses the many techniques of nanocarrier functionalization with antibodies. The aim is to recognize the various approaches by describing their advantages and deficiencies to create the most suitable drug delivery platform. Some methods are more suitable for other applications rather than drug delivery, which can explain the low success of some proposed targeted nanocarriers.